Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
Leukemia and Lymphoma
Just as cancer takes many forms, so does genetic testing. Here’s what you need to know.
Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.
One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.
As genomics continues to evolve, here are five things to know about genetic testing and counseling.
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.
Acute myeloid leukemia experts share promising new developments on the oncology horizon.
Physicians need to be able to move quickly to care for patients with AML, and they need to have payers on board.
Oncology is a complex and rapidly-evolving management challenge for payers.